TaiGen Biopharmaceuticals Holdings Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 23.422 million compared to TWD 20.314 million a year ago. Operating loss was TWD 307.319 million compared to TWD 277.133 million a year ago. Net loss was TWD 404.819 million compared to TWD 295.685 million a year ago. Basic loss per share was TWD 0.56 compared to TWD 0.41 a year ago.